Oxford University spinout OrganOx to be acquired by Terumo for a record $1.5bn

Published on August 25, 2025

An agreement has been reached for the acquisition of OrganOx, a pioneering University of Oxford spinout transforming kidney and liver transplantation, by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion. The transaction, which is subject to regulatory and other approvals, would be the largest acquisition of an Oxford University spinout to date, and one of the most significant venture capital exits in UK university spinout history.
Continue reading on website
Other news

Chronic pain research breakthrough identifies promising drug target

August 22, 2025
A new paper published in Nature shows how, in a collaborative project across diverse medical disciplines, Oxford researchers from the Nuffield Department of Clinical Neurosciences (NDCN) and the Department of Biochemistry have identified a new genetic link to pain.

Trump shooting and Biden exit flipped social media from hostility to solidarity

August 26, 2025
While previous research shows outrage and division drive engagement on social media, a new study of digital behaviour during the 2024 US election finds that this effect flips during a major crisis – when “ingroup solidarity” becomes the engine of online virality.Psychologists say the findings show positive emotions such as unity can cut through the hostility on social media, but it takes a shock t